Biotech Research

PARIS (Reuters) - French drugmaker Sanofi-Aventis poured cold water on reports it had raised its offer for Genzyme , saying it was sticking to its bid of $18.5 billion, or $69 per share. "There is one offer, at $69 a share," spokeman Jean-Marc Podvin said on Thursday. "No other offer has been made to or discussed with the Genzyme board, its ...

Cleaning validation procedures are an integral part of pharmaceutical manufacturing. It is of utmost importance to ensure that the process of cleaning validation is performed properly to ensure that there is no incidence of cross-contamination in the manufacturing process.

Custom Sensors and Technology, based in Fenton MO, has the equipment necessary to perform proper cleaning validation. Their LIF [Light Induced ...

Pharmaceutical training is essential for medical device businesses, pharmaceutical companies and nutraceutical organisations that play a huge role in our everyday lives. They carry out an important role in providing the world's national health services with quality products that can enable them to treat patients with the very best care and medical attention.

Of course, because many of the ...

Recently I have been looking into the biomechanics of golf swing. I was not keen on looking at it to start with as just the name made me think that it would be very complicated and that I would not be able to understand it. I kept seeing it mentioned and just ignoring everything to do with it.

However, I ...

Emergent BioSolutions purchase of Trubion Pharma clears regulatory hurdle early

The planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle Wednesday, bringing the deal, potentially worth $135.5 million, closer to closing. The Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Act for the acquisition, Trubion ...

Yunnan Wenshan drought concern. Nearly 97% of the 37 were produced in Yunnan Wenshan. The 37 bases of the seedlings in the Yanshan County, Wenshan Prefecture. However, because of drought, coupled with drug hoarding, the price of 37 from 70 yuan per kilogram last year rose to 440 yuan yesterday.
Carrying water for irrigation to spend 60,000 yuan mu ...

BOSTON (Reuters) - Sanofi-Aventis SA pitched a new offer to acquire U.S. biotechnology company Genzyme Corp for $71 a share in exchange for the opportunity to conduct "partial due diligence," according to DealReporter, which cited a source close to the discussions. DealReporter, a financial news service affiliated with the Financial Times Group, said the $71 offer is likely Sanofi's ...

Bristol-Myers Squibb says it will buy ZymoGenetics for $885M, or $9.75 per share in cash

Bristol-Myers Squibb Co. says it will acquire biotechnology company ZymoGenetics Inc. for $885 million, or $9.75 per share. The New York drugmaker says its bid is worth $735 million excluding ZymoGenetics' cash on hand. Shares of ZymoGenetics closed at $5.51 Tuesday, making ...

Merck: Arbitration with Johnson & Johnson over arthritis drugs' revenue to start in weeks

Drugmaker Merck & Co. says arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis. The dispute arose when Merck bought Schering-Plough Corp., which has shared billions in revenue with J&J from Remicade and a successor ...

PARIS (Reuters) - French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones reported, citing a person familiar with the matter. The person played down recent reports that Sanofi's board was split over whether to pursue the deal after Genzyme rejected its initial offer ...

Previous

1
2
3
4
5

Home

The Latest Stories

Sanofi sticks to $69 per share Genzyme offer

Custom Sensors And Technology Cleaning Validation

How Does Pharmaceutical Training Benefit Medical Businesses

Biomechanics Of Golf Swing

Emergent's Trubion buyout clears regulatory hurdle

Yunnan 37 due to a severe drought cut into three price spikes carrying water for irrigation mu

Sanofi pitched $71 offer to Genzyme: report

Bristol-Myers agrees to buy ZymoGenetics for $885M

Merck, J&J arbitration on drug rights starts soon

Sanofi ready to raise bid if Genzyme talks: report

Photo Gallery